Inappropriate inclusion of multiple studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome

Eur Heart J. 2019 Mar 14;40(11):941-942. doi: 10.1093/eurheartj/ehz072.

Authors

Ricky D Turgeon¹, Andrew D Althouse²

Affiliations

¹ Department of Pharmacy, Vancouver General Hospital, G23-855 West 12th Ave, Vancouver, British Columbia, Canada.
² Division of General Internal Medicine, Center for Research on Health Care Data Center (CRHC-DC), Center for Clinical Trials & Data Coordination (CCDC), University of Pittsburgh School of Medicine, 200 Meyran Avenue, Pittsburgh PA, USA.

PMID: 30783662
DOI: 10.1093/eurheartj/ehz072

No abstract available

Publication types

Comment

MeSH terms

Acute Coronary Syndrome*
Atorvastatin
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Percutaneous Coronary Intervention*
Randomized Controlled Trials as Topic

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atorvastatin